Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7422867
APP PUB NO 20080108066A1
SERIAL NO

11784176

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a CLLD8 protein as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RIGEL PHARMACEUTICALS INCCALIFORNIA USA CALIFORNIA

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Anderson, David C San Bruno, CA 51 1858
Bennett, Mark K Moraga, CA 53 621
Kinoshita, Taisei San Mateo, CA 25 59
Kinsella, Todd M Redwood City, CA 39 155
Masuda, Esteban Menlo Park, CA 111 1173
Warner, Justin E San Francisco, CA 17 12

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation